Fuller & Thaler Asset Management, Inc. Invitae Corp Transaction History

Fuller & Thaler Asset Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 14, 2019	SELL	$9.26 - $16.38 $2.42 Million - $4.29 Million	-261,800 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$7.54 - $18.31 $1.97 Million - $4.79 Million	261,800 New	261,800 $4.38 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.